Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 12:24 AM
NCT ID:
NCT00671658
Eligibility Criteria:
Inclusion Criteria:
1. Newly diagnosed, previously untreated Acute Lymphoblastic Leukemia (ALL) or lymphoblastic lymphoma, or having achieved Complete Remission (CR) with one course of induction chemotherapy.
2. Failure to one induction course of chemotherapy are eligible, but these patients will be analyzed separately.
3. All ages are eligible.
4. Zubrod performance less than or equal to 3
5. Adequate liver function (bilirubin \</= 3.0 mg/dl unless considered due to tumor) and renal function (creatinine \</= 3.0 mg/dl, unless considered due to tumor).
6. Adequate cardiac function as assessed by history and physical examination.
7. No active co-existing malignancy with life expectancy less than 12 months due to that malignancy.
Exclusion Criteria:
1\) N/A
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00671658
Study Brief:
Protocol Section:
NCT00671658